Static Chart PharmaEssentia Corporation

Equities

End-of-day quote Taiwan S.E. Other stock markets 06:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
593 ^TWD	+1.54%		+7.04%	+71.39%

Jul. 05	Pharmaessentia Corporation Receives Approval of China National Medical Products Administration for Application of Ropeginterferon alfa-2b for PV	CI
Jul. 02	PharmaEssentia Corporation Announces Update on its IND Application of Phase I Clinical Trial of Sequential Treatment of P1801 Following P1101 in Patients with Advanced Solid Tumors	CI

Duration

Period